JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1971) 50, 373-381    DOI: 10.1677/joe.0.0500373
© 1971 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DILMAN, V. M.
Right arrow Articles by VASIL'EVA, I. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by DILMAN, V. M.
Right arrow Articles by VASIL'EVA, I. A.

INHIBITION OF LIPOLYSIS AND POTENTIATION OF THE HYPOGLYCAEMIC EFFECT OF INSULIN BY NON-HYPOGLYCAEMIC INSULIN DERIVATIVES

V. M. DILMAN and I. A. VASIL'EVA

Treatment of insulin with iodine or formaldehyde eliminates its hypoglycaemic effect but does not affect the antilipolytic properties of insulin. Pharmacological doses of iodinated insulin injected into rabbits inhibit the lipolysis caused by human growth hormone, corticotrophin, lipotrophin or fasting.

Iodinated or formaldehyde-treated insulin was found to increase the hypoglycaemic effect of exogenous native insulin. This action may be accounted for by the antilipolytic activity of these insulin derivatives. Iodinated insulin could also be shown to decrease the glycaemia after a glucose load.

The significance of increased lipolysis in the pathogenesis of a large group of pathological conditions caused by increased resistance of the hypothalamus to homeostatic inhibition is discussed.







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1971 by the Society for Endocrinology.